General Information of Drug (ID: DMNJ7LY)

Drug Name
SB 203186 Drug Info
Synonyms
SB 203186; SB-203186; 2-piperidin-1-ylethyl 1H-indole-3-carboxylate; Tocris-0785; NCGC00015921-01; Lopac-S-0443; Biomol-NT_000150; AC1MN68M; Lopac0_000347; GTPL255; BPBio1_000617; SCHEMBL1041116; CHEMBL1255781; ZINC14457; CHEBI:92477; BDBM85778; YGKPIROTKVQCCU-UHFFFAOYSA-N; CCG-204442; NCGC00024790-03; NCGC00015921-02; NCGC00024790-01; NCGC00024790-02; NCGC00015921-04; NCGC00015921-03; CAS_135938-17-9; (1-piperidinyl)ethyl 1h-indole 3-carboxylate; 2-(1-piperidyl)ethyl 1H-indole-3-carboxylate; 2-(1-Piperidyl)ethyl 1 H-indole-3-carboxy
Cross-matching ID
PubChem CID
3272300
ChEBI ID
CHEMBL92477
TTD Drug ID
D0E8KS

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Autoimmune thyroid disease 2.22 0.00e+0 46/53 (86.79%) HLA-DQB1;PRF1;HLA-DPB1;...
Allograft rejection 2.21 0.00e+0 32/38 (84.21%) HLA-DQB1;PRF1;HLA-DPB1;...
Proteasome 1.99 0.00e+0 44/46 (95.65%) PSMA3;PSMC3;PSMD6;...
Type I diabetes mellitus 1.99 0.00e+0 38/43 (88.37%) HLA-DQB1;PRF1;HLA-DPB1;...
Graft-versus-host disease 1.98 0.00e+0 32/42 (76.19%) HLA-DQB1;PRF1;HLA-DPB1;...
Systemic lupus erythematosus 1.87 1.12e-2 45/135 (33.33%) HLA-DQB1;C1QA;HLA-DPB1;...
T cell receptor signaling pathway 1.83 1.73e-2 93/104 (89.42%) RASGRP1;RHOA;CD3D;...
Intestinal immune network for IgA production 1.82 1.51e-2 38/48 (79.17%) HLA-DQB1;HLA-DPB1;TNFRSF17;...
Viral myocarditis 1.79 1.64e-2 53/60 (88.33%) HLA-DQB1;PRF1;HLA-DPB1;...
Natural killer cell mediated cytotoxicity 1.75 2.28e-2 99/131 (75.57%) PRF1;SHC1;ICAM1;...
Antigen processing and presentation 1.73 2.44e-2 60/78 (76.92%) HLA-DQB1;HLA-DPB1;CD8A;...
Ovarian steroidogenesis -1.86 3.18e-2 41/51 (80.39%) PLA2G4A;INS;IGF1R;...
Steroid biosynthesis -2.21 0.00e+0 19/20 (95%) TM7SF2;NSDHL;SOAT1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H, 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H, 24H